Literature DB >> 24298019

Notch-Nrf2 axis: regulation of Nrf2 gene expression and cytoprotection by notch signaling.

Nobunao Wakabayashi1, John J Skoko, Dionysios V Chartoumpekis, Shoko Kimura, Stephen L Slocum, Kentaro Noda, Dushani L Palliyaguru, Masahiro Fujimuro, Patricia A Boley, Yugo Tanaka, Norihisa Shigemura, Shyam Biswal, Masayuki Yamamoto, Thomas W Kensler.   

Abstract

The Notch signaling pathway enables regulation and control of development, differentiation, and homeostasis through cell-cell communication. Our investigation shows that Notch signaling directly activates the Nrf2 stress adaptive response pathway through recruitment of the Notch intracellular domain (NICD) transcriptosome to a conserved Rbpjκ site in the promoter of Nrf2. Stimulation of Notch signaling through Notch ligand expression in cells and by overexpression of the NICD in Rosa(NICD/-)::AlbCre mice in vivo induces expression of Nrf2 and its target genes. Continuous and transient NICD expression in the liver produces a Notch-dependent cytoprotective response through direct transcriptional activation of Nrf2 signaling to rescue mice from acute acetaminophen toxicity. This response can be reversed upon genetic disruption of Nrf2. Morphological studies showed that the characteristic phenotype of high-density intrahepatic bile ducts and enlarged liver in Rosa(NICD/-)::AlbCre mice could be at least partially reversed after Nrf2 disruption. Furthermore, the liver and bile duct phenotypes could be recapitulated with constitutive activation of Nrf2 signaling in Keap1(F/F)::AlbCre mice. It appears that Notch-to-Nrf2 signaling is another important determinant in liver development and function and promotes cell-cell cytoprotective signaling responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24298019      PMCID: PMC3911489          DOI: 10.1128/MCB.01408-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

Review 1.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

Authors:  Thomas W Kensler; Nobunao Wakabayashi; Shyam Biswal
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

2.  CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.

Authors:  Scott A Reisman; David B Buckley; Yuji Tanaka; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-20       Impact factor: 4.219

Review 3.  The cytoprotective Nrf2 transcription factor controls insulin receptor signaling in the regenerating liver.

Authors:  Tobias A Beyer; Sabine Werner
Journal:  Cell Cycle       Date:  2008-01-18       Impact factor: 4.534

Review 4.  Notch signaling in gastrointestinal tract (review).

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Oncol       Date:  2007-01       Impact factor: 5.650

5.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1.

Authors:  Masaaki Komatsu; Hirofumi Kurokawa; Satoshi Waguri; Keiko Taguchi; Akira Kobayashi; Yoshinobu Ichimura; Yu-Shin Sou; Izumi Ueno; Ayako Sakamoto; Kit I Tong; Mihee Kim; Yasumasa Nishito; Shun-ichiro Iemura; Tohru Natsume; Takashi Ueno; Eiki Kominami; Hozumi Motohashi; Keiji Tanaka; Masayuki Yamamoto
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

Review 6.  Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses.

Authors:  S Diane Hayward; Jianyong Liu; Masahiro Fujimuro
Journal:  Sci STKE       Date:  2006-05-16

7.  Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice.

Authors:  Fabian Geisler; Florian Nagl; Pawel K Mazur; Marcel Lee; Ursula Zimber-Strobl; Lothar J Strobl; Freddy Radtke; Roland M Schmid; Jens T Siveke
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

8.  Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems.

Authors:  Kosuke Okada; Junichi Shoda; Keiko Taguchi; Jonathan M Maher; Kaoru Ishizaki; Yoshimi Inoue; Makio Ohtsuki; Nobuharu Goto; Hirokazu Sugimoto; Hirotoshi Utsunomiya; Koji Oda; Eiji Warabi; Tetsuro Ishii; Masayuki Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2009-09-02       Impact factor: 3.575

Review 9.  Nrf2: friend or foe for chemoprevention?

Authors:  Thomas W Kensler; Nobunao Wakabayashi
Journal:  Carcinogenesis       Date:  2009-09-30       Impact factor: 4.944

10.  Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2.

Authors:  Lauren M Aleksunes; Angela L Slitt; Jonathan M Maher; Lisa M Augustine; Michael J Goedken; Jefferson Y Chan; Nathan J Cherrington; Curtis D Klaassen; José E Manautou
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-31       Impact factor: 4.219

View more
  53 in total

Review 1.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

2.  Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.

Authors:  Abigail G Zieman; Brian G Poll; Jingqun Ma; Pierre A Coulombe
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

Review 3.  Nrf2 at the heart of oxidative stress and cardiac protection.

Authors:  Qin M Chen; Anthony J Maltagliati
Journal:  Physiol Genomics       Date:  2017-11-29       Impact factor: 3.107

4.  Nrf2 Activation Inhibits Effects of Thrombin in Human Amnion Cells and Thrombin-Induced Preterm Birth in Mice.

Authors:  Yoshitsugu Chigusa; Annavarapu Hari Kishore; Haruta Mogami; Ruth Ann Word
Journal:  J Clin Endocrinol Metab       Date:  2016-04-06       Impact factor: 5.958

5.  Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver.

Authors:  Min Hu; Yuhong Zou; Shashank Manohar Nambiar; Joonyong Lee; Yan Yang; Guoli Dai
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 6.  Crosstalk between Nrf2 and Notch signaling.

Authors:  Nobunao Wakabayashi; Dionysios V Chartoumpekis; Thomas W Kensler
Journal:  Free Radic Biol Med       Date:  2015-05-21       Impact factor: 7.376

7.  Alcohol drinking inhibits NOTCH-PAX9 signaling in esophageal squamous epithelial cells.

Authors:  Menghan Shi; Shuang Ren; Hao Chen; Jing Li; Caizhi Huang; Yahui Li; Yuning Han; Yong Li; Zheng Sun; Xiaoxin Chen; Zhaohui Xiong
Journal:  J Pathol       Date:  2021-01-18       Impact factor: 7.996

8.  Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2.

Authors:  Md Morshedul Alam; Keito Okazaki; Linh Thi Thao Nguyen; Nao Ota; Hiroshi Kitamura; Shohei Murakami; Hiroki Shima; Kazuhiko Igarashi; Hiroki Sekine; Hozumi Motohashi
Journal:  J Biol Chem       Date:  2017-03-17       Impact factor: 5.157

Review 9.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

10.  Mutations and expression of the NFE2L2/KEAP1/CUL3 pathway in Chinese patients with lung squamous cell carcinoma.

Authors:  Yongxing Zhang; Hong Fan; Shuo Fang; Lin Wang; Li Chen; Yulin Jin; Wei Jiang; Zongwu Lin; Yu Shi; Cheng Zhan; Qun Wang
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.